What factors determine the initial chemotherapy regimen recommended for ovarian cancer patients? Is this usually standard, or are there multiple options?
Clinical trials (research studies) have been performed over the years to determine the most effective chemotherapy regimens for ovarian cancer. In the United States, the most common regimen prescribed includes two drugs -- a platinum-based drug (most often carboplatin) plus a chemotherapy from the class of chemotherapy drugs known as taxanes (such as paclitaxel or docetaxel). This regimen is standard in the US, however, research studies are ongoing to determine if other regimens might give better results. Also, individual patients might be offered slightly different chemotherapy drugs depending on other factors, such as whether the patient has kidney or liver abnormalities.
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.
Note: All content on this site is informational and not a substitute for professional medical advice.
Always seek the advice of your physician or other qualified health provider with questions regarding your health.
Flag Content
Please expain why you are flagging this content. Thank you.
Only one answer per conversation per user. You may edit your answer though.
Question:
Optional: What context or background information is relevant to this request?
Notes:
The more clear and thorough your request, the more likely you will receive support.
Many of our members are learning from this information
or english might not be their first language.
Please use standard english and spell out all words.
For example, use 'you' instead of 'u'.
Call SHARE at: 866-891-2392
to speak directly to a trained breast cancer survivor for support and guidance.
3 Quick Ways You Can Help
1) Spread the word! Tell people you think might want some support. Tell medical professionals, health providers, and organizations.
2) Like us on Facebook and follow us on Twitter! 3) Volunteer - email us at volunteer@talkabouthealth.com for more information.